Health Care & Life Sciences » Pharmaceuticals | Tong Ren Tang Technologies Co. Ltd.

Tong Ren Tang Technologies Co. Ltd. | Ownership

Companies that own Tong Ren Tang Technologies Co. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
First State Investments (Hong Kong) Ltd.
64,294,000
10.23%
-16,593,000
0.86%
09/03/2018
Hillhouse Capital Management Ltd. (Hong Kong)
47,736,000
7.59%
0
0.78%
06/30/2017
The Vanguard Group, Inc.
21,286,188
3.39%
1,127,976
0%
07/31/2018
UBS Asset Management (Hong Kong) Ltd.
13,703,000
2.18%
-1,039,000
0.45%
01/31/2018
Aberdeen Asset Management (Asia) Ltd.
13,581,000
2.16%
-4,090,000
0.1%
05/31/2018
First State Investment Management (UK) Ltd.
11,475,000
1.83%
-12,256,000
0.08%
09/03/2018
BlackRock Fund Advisors
10,667,000
1.7%
-304,000
0%
06/04/2018
Norges Bank Investment Management
10,110,013
1.61%
-3,199,987
0%
12/31/2017
Dimensional Fund Advisors LP
8,723,000
1.39%
157,000
0%
04/30/2018
Aberdeen International Fund Managers Ltd.
7,615,000
1.21%
-545,000
1.61%
07/31/2018

About Tong Ren Tang Technologies Co.

View Profile
Address
No.20 Nansanhuan Zhonglu
Beijing Beijing 100079
China
Employees -
Website http://www.tongrentangkj.com
Updated 07/08/2019
Tong Ren Tang Technologies Co., Ltd. engages in the production and distribution of Chinese medicine. Its products include Liuwei Dihuang pills, Niuhuang Jiedu tablet, Ganmao Qingre granule, Jinkui Shenqi pills, Shengmai liquor, Xihuang pills and Fufang Danshen tablets. The company was founded on March 22, 2000 and is headquartered in Beijing, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.